Differential induction of innate defense antimicrobial peptides in primary nasal epithelial cells upon stimulation with inflammatory cytokines, Th17 cytokines or bacterial conditioned medium from Staphylococcus aureus isolates

Microbial Pathogenesis

Volumn 90, Issue , 2016, Pages 69-77

  Burgey, Christine ^a,b   Kern, Winfried V ^a   Römer, Winfried ^b   Rieg, Siegbert ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Bacteremia; Colonization; Host pathogen interaction; Infection; Nasal carriage; Staphylococcus aureus

Indexed keywords

BETA DEFENSIN; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; GAMMA INTERFERON; INTERLEUKIN 1BETA; MESSENGER RNA; POLYPEPTIDE ANTIBIOTIC AGENT; PROTEIN RNASE7; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; ANTIMICROBIAL CATIONIC PEPTIDE; BETA-DEFENSIN 3, HUMAN; CAP18 LIPOPOLYSACCHARIDE-BINDING PROTEIN; CONDITIONED MEDIUM; CYTOKINE; RIBONUCLEASE; RIBONUCLEASE 7;

ARTICLE; BACTERIUM ISOLATE; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37 GENE; CELL STIMULATION; CONTROLLED STUDY; GENE EXPRESSION; HBD3 GENE; HUMAN; HUMAN CELL; IN VITRO STUDY; INNATE IMMUNITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; RNASE7 GENE; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; BIOSYNTHESIS; CONDITIONED MEDIUM; EPITHELIUM CELL; GENETICS; HETEROZYGOTE; HOST PATHOGEN INTERACTION; IMMUNOLOGY; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; NOSE MUCOSA; STAPHYLOCOCCUS INFECTION; UPREGULATION;

ANTI-BACTERIAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; BETA-DEFENSINS; CARRIER STATE; CULTURE MEDIA, CONDITIONED; CYTOKINES; EPITHELIAL CELLS; GENE EXPRESSION; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; NASAL MUCOSA; RIBONUCLEASES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; UP-REGULATION;

EID: 84963757397     PISSN: 08824010     EISSN: 10961208     Source Type: Journal    
DOI: 10.1016/j.micpath.2015.11.023     Document Type: Article

References (37)

1. Wertheim H.F., Melles D.C., Vos M.C., van Leeuwen W., van Belkum A., Verbrugh H.A., et al. The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect. Dis. 2005, 5(12):751-762.
2. Nouwen J.L., Ott A., Kluytmans-Vandenbergh M.F., Boelens H.A., Hofman A., van Belkum A., et al. Predicting the Staphylococcus aureus nasal carrier state: derivation and validation of a "culture rule". Clin. Infect. Dis. 2004, 39(6):806-811.
3. Brown K.L., Hancock R.E. Cationic host defense (antimicrobial) peptides. Curr. Opin. Immunol. 2006, 18(1):24-30.
4. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature 2002, 415(6870):389-395.
5. Guani-Guerra E., Santos-Mendoza T., Lugo-Reyes S.O., Teran L.M. Antimicrobial peptides: general overview and clinical implications in human health and disease. Clin. Immunol. 2010, 135(1):1-11.
6. Bulet P., Stocklin R., Menin L. Anti-microbial peptides: from invertebrates to vertebrates. Immunol. Rev. 2004, 198:169-184.
7. Joly S., Organ C.C., Johnson G.K., McCray P.B., Guthmiller J.M. Correlation between beta-defensin expression and induction profiles in gingival keratinocytes. Mol. Immunol. 2005, 42(9):1073-1084.
8. Harder J., Bartels J., Christophers E., Schroder J.M. Isolation and characterization of human beta -defensin-3, a novel human inducible peptide antibiotic. J. Biol. Chem. 2001, 276(8):5707-5713.
9. Kao C.Y., Chen Y., Thai P., Wachi S., Huang F., Kim C., et al. IL-17 markedly up-regulates beta-defensin-2 expression in human airway epithelium via JAK and NF-kappaB signaling pathways. J. Immunol. 2004, 173(5):3482-3491.
10. Liang S.C., Tan X.Y., Luxenberg D.P., Karim R., Dunussi-Joannopoulos K., Collins M., et al. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J. Exp. Med. 2006, 203(10):2271-2279.
11. Simanski M., Rademacher F., Schroder L., Schumacher H.M., Glaser R., Harder J. IL-17A and IFN-gamma synergistically induce RNase 7 expression via STAT3 in primary keratinocytes. PLoS One 2013, 8(3):e59531.
12. Wolk K., Kunz S., Witte E., Friedrich M., Asadullah K., Sabat R. IL-22 increases the innate immunity of tissues. Immunity 2004, 21(2):241-254.
13. Minegishi Y., Saito M., Nagasawa M., Takada H., Hara T., Tsuchiya S., et al. Molecular explanation for the contradiction between systemic Th17 defect and localized bacterial infection in hyper-IgE syndrome. J. Exp. Med. 2009, 206(6):1291-1301.
14. Wanke I., Steffen H., Christ C., Krismer B., Gotz F., Peschel A., et al. Skin commensals amplify the innate immune response to pathogens by activation of distinct signaling pathways. J. Investig. Dermatol. 2011, 131(2):382-390.
15. Menzies B.E., Kenoyer A. Staphylococcus aureus infection of epidermal keratinocytes promotes expression of innate antimicrobial peptides. Infect. Immun. 2005, 73(8):5241-5244.
16. Simanski M., Dressel S., Glaser R., Harder J. RNase 7 protects healthy skin from Staphylococcus aureus colonization. J. Investig. Dermatol. 2010, 130(12):2836-2838.
17. Zanger P., Holzer J., Schleucher R., Steffen H., Schittek B., Gabrysch S. Constitutive expression of the antimicrobial peptide RNase 7 is associated with Staphylococcus aureus infection of the skin. J. Infect. Dis. 2009, 200(12):1907-1915.
18. Zanger P., Nurjadi D., Vath B., Kremsner P.G. Persistent nasal carriage of Staphylococcus aureus is associated with deficient induction of human beta-defensin 3 after sterile wounding of healthy skin in vivo. Infect. Immun. 2011, 79(7):2658-2662.
19. Zanger P., Holzer J., Schleucher R., Scherbaum H., Schittek B., Gabrysch S. Severity of Staphylococcus aureus infection of the skin is associated with inducibility of human beta-defensin 3 but not human beta-defensin 2. Infect. Immun. 2010, 78(7):3112-3117.
20. Boukamp P., Petrussevska R.T., Breitkreutz D., Hornung J., Markham A., Fusenig N.E. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J. Cell Biol. 1988, 106(3):761-771.
21. Moorhead P.S. Human tumor cell line with a quasi-diploid karyotype (RPMI 2650). Exp. Cell Res. 1965, 39(1):190-196.
22. Rieg S., Jonas D., Kaasch A.J., Porzelius C., Peyerl-Hoffmann G., Theilacker C., et al. Microarray-based genotyping and clinical outcomes of Staphylococcus aureus bloodstream infection: an exploratory study. PLoS One 2013, 8(8):e71259.
23. Kaus A., Jacobsen F., Sorkin M., Rittig A., Voss B., Daigeler A., et al. Host defence peptides in human burns. Burns 2008, 34(1):32-40.
24. de Kok J.B., Roelofs R.W., Giesendorf B.A., Pennings J.L., Waas E.T., Feuth T., et al. Normalization of gene expression measurements in tumor tissues: comparison of 13 endogenous control genes. Lab. Investig. 2005, 85(1):154-159.
25. Harder J., Schroder J.M. RNase 7, a novel innate immune defense antimicrobial protein of healthy human skin. J. Biol. Chem. 2002, 277(48):46779-46784.
26. Albanesi C., Fairchild H.R., Madonna S., Scarponi C., De P.O., Leung D.Y., et al. IL-4 and IL-13 negatively regulate TNF-alpha- and IFN-gamma-induced beta-defensin expression through STAT-6, suppressor of cytokine signaling (SOCS)-1, and SOCS-3. J. Immunol. 2007, 179(2):984-992.
27. Ganz T. Antimicrobial polypeptides in host defense of the respiratory tract. J. Clin. Investig. 2002, 109(6):693-697.
28. Laudien M., Dressel S., Harder J., Glaser R. Differential expression pattern of antimicrobial peptides in nasal mucosa and secretion. Rhinology 2011, 49(1):107-111.
29. Cole A.M., Tahk S., Oren A., Yoshioka D., Kim Y.H., Park A., et al. Determinants of Staphylococcus aureus nasal carriage. Clin. Diagn. Lab. Immunol. 2001, 8(6):1064-1069.
30. Lai Y., Cogen A.L., Radek K.A., Park H.J., Macleod D.T., Leichtle A., et al. Activation of TLR2 by a small molecule produced by Staphylococcus epidermidis increases antimicrobial defense against bacterial skin infections. J. Investig. Dermatol. 2010, 130(9):2211-2221.
31. Quinn G.A., Cole A.M. Suppression of innate immunity by a nasal carriage strain of Staphylococcus aureus increases its colonization on nasal epithelium. Immunology 2007, 122(1):80-89.
32. Koten B., Becker K., Podschun R., von Eiff C., Meyer-Hoffert U., Harder J., et al. Susceptibility of Staphylococcus aureus bacteremia strains to different skin-derived antimicrobial proteins. Arch. Dermatol. Res. 2012, 304(8):633-637.
33. Rieg S., Kaasch A.J., Wehrle J., Hofmann S.C., Szymaniak-Vits M., Saborowski V., et al. Susceptibility of clinical Staphylococcus aureus isolates to innate defense antimicrobial peptides. Microbes Infect. 2011, 13(8-9):761-765.
34. Nurjadi D., Herrmann E., Hinderberger I., Zanger P. Impaired beta-defensin expression in human skin links DEFB1 promoter polymorphisms with persistent Staphylococcus aureus nasal carriage. J. Infect. Dis. 2013, 207(4):666-674.
35. Holland D.B., Bojar R.A., Farrar M.D., Holland K.T. Differential innate immune responses of a living skin equivalent model colonized by Staphylococcus epidermidis or Staphylococcus aureus. FEMS Microbiol. Lett. 2009, 290(2):149-155.
36. Ommori R., Ouji N., Mizuno F., Kita E., Ikada Y., Asada H. Selective induction of antimicrobial peptides from keratinocytes by staphylococcal bacteria. Microb. Pathog. 2013, 56:35-39.
37. Werner U., Kissel T. In-vitro cell culture models of the nasal epithelium: a comparative histochemical investigation of their suitability for drug transport studies. Pharm. Res. 1996, 13(7):978-988.